| Date | Title | Description |
| 09.04.2026 | AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages | As regulatory demands intensify and production environments become more complex, pharmaceutical manufacturers are shifting beyond traditional quality assurance systems toward a new operational model: integrating artificial intelligence dire... |
| 08.04.2026 | Drugmaker FDC goes to court on similar-sounding electrolyte drink eRZL from J&J/Kenvue | - |
| 06.04.2026 | Biotech Firm Gets a New Leader
New chief chosen | - |
| 01.04.2026 | Thursday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 31.03.2026 | Wednesday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 31.03.2026 | Amani Therapeutics: $25 Million Raised To Advance Neuropsychiatric Therapy AM-01 | Amani Therapeutics has raised $25 million in a Series A financing to advance its lead program, AM-01, a potential best-in-class therapy targeting serious neuropsychiatric disorders.
The newly formed biotechnology company, backed by RTW Inve... |
| 30.03.2026 | Stratum Biosciences Raises $2M in Seed Funding | Stratum Biosciences, a NYC-based biotechnology company at the intersection of artificial intelligence and dermatology research, closed a $2M seed funding.
Backers included the Harvard Business School Alumni Angels of Greater New York and Sk... |
| 30.03.2026 | Tuesday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 28.03.2026 | Stratum Biosciences: $2 Million Raised To Advance AI-Powered Skin Biology Discovery Platform | Stratum Biosciences has secured $2 million in seed funding to accelerate development of its AI-powered skin biology discovery platform and expand research and development partnerships. The round was backed by Harvard Business School Alumni ... |
| 26.03.2026 | Friday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 25.03.2026 | SI Group Earns Silver EcoVadis Rating, Recognized Among Top 15% Globally | Recognition Reflects Progress Detailed in the Company's 2025 ESG Report
THE WOODLANDS, Texas, March 25, 2026 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, and chemical int... |
| 25.03.2026 | Thursday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 24.03.2026 | Wednesday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 23.03.2026 | Tuesday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 21.03.2026 | Biotech Powerhouse Mestag Therapeutics Secures $40M for Advanced Therapies | Mestag Therapeutics has secured $40 million in new financing. This pushes its total funding past $95 million. The Cambridge-based biotech fuels its Phase 1 STARLYS clinical trial for cancer drug MST-0312. This pivotal trial begins in mid-20... |
| 21.03.2026 | A slew of consumer stocks are now oversold as S&P 500 falls for a fourth week in a row | - |
| 20.03.2026 | GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer | SEOUL, South Korea, March 20, 2026 /PRNewswire/ -- GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy in patients with metastatic castration-resi... |
| 19.03.2026 | Nvidia Accelerates Open AI Frontier with Broad Model Expansion | Nvidia pushes open AI innovation. New models empower AI agents, physical systems, and healthcare. The company expands Nemotron for multimodal intelligence. It introduces Cosmos, GR00T, and Alpamayo for robotics and autonomous vehicles. BioN... |
| 19.03.2026 | Friday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 18.03.2026 | Wednesday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 18.03.2026 | FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi | Johnson & Johnson said the FDA has approved its once-daily psoriasis pill Icotyde.
Icotyde targets IL-23, rivaling best-selling shots Tremfya and Skyrizi.
J&J hasn’t announced how much Icotyde will cost. J&J sees annual sales ex... |
| 18.03.2026 | Thursday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 17.03.2026 | Mestag Therapeutics Raises $40M in Financing | Mestag Therapeutics, a Cambridge, UK-based biotech company harnessing fibroblast immunology to develop treatments for cancer and inflammatory diseases, closed a $40m financing.
Backers includwed SV Health Investors, Johnson & Johnson, t... |
| 17.03.2026 | NVIDIA Expands Open Model Families to Power the Next Wave of Agentic, Physical and Healthcare AI | announced it is expanding its open model families to power the next wave of agentic, physical and healthcare AI, introducing new models that enable developers and scientists to build intelligent systems that can reason and act across digita... |
| 16.03.2026 | Tuesday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 15.03.2026 | Here are the 5 big things we’re watching in the stock market in the week ahead | - |
| 13.03.2026 | These stocks will benefit from AI and an aging population, Jefferies says. They also pay dividends | - |
| 12.03.2026 | Dividend stocks are going gangbusters in 2026. Here’s what investors are doing with the extra cash | - |
| 10.03.2026 | Bright spots in tackling AMRs, but drug-resistance outpaces pharma industry efforts: Report | - |
| 09.03.2026 | Healthcare AI pilots outpace sector's regulatory readiness | - |
| 03.03.2026 | Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform | NEW YORK, March 3, 2026 /PRNewswire/ -- Royalty Pharma plc (Nasdaq: RPRX) announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company's royalty ... |
| 02.03.2026 | Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis | SHANGHAI, HANGZHOU, China and BOSTON, March 2, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory dis... |
| 02.03.2026 | Tackling maternal isolation through tech & community | - |
| 02.03.2026 | Eskom to rationalise AI pilots as costs rise | Eskom CTIO Len de Villiers
State-owned power producer Eskom is looking to cut the number of AI pilots across the organisation in a bid to avoid wasteful expenditure, according to its CTIO, Len de Villiers.
Speaking at the industrial digital... |
| 28.02.2026 | Novo Nordisk Faces Setback as Key Weight Loss Drug Falls Short | Novo Nordisk experienced a significant blow. Its experimental weight-loss medication, CagriSema, failed to meet expectations in a crucial clinical trial. The drug did not demonstrate non-inferiority against Eli Lilly's rival product, tirzep... |
| 27.02.2026 | We’re adding a stock to our Bullpen watchlist that is resistant to recessions and AI disruption | - |
| 27.02.2026 | New speakers for Tech.eu Summit London, the reality of Ukraine’s tech ecosystem four years on, and IQM to go public | This week, we tracked more than 70 tech funding deals worth over €2 billion and 5 exits, M&A transactions, rumours, and related news stories across Europe.
On the fourth anniversary of Russia’s unprovoked full-scale invasion of Ukraine,... |
| 27.02.2026 | There’s a ‘bearish-to-bullish’ reversal happening in this mid-cap biotech stock, says Carter Worth | - |
| 26.02.2026 | Bizarro world: Tech is now almost as cheap as consumer staples stocks | - |
| 25.02.2026 | Early Alert: Heart Pump Purge Cassette Issue from Abiomed | CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. Affected Product
The FDA is awar... |
| 24.02.2026 |
Jim Cramer’s simple framework for identifying winners in a market fearful of AI disruption | Monday - Friday, 6:00 - 7:00 PM ET
CNBC’s Jim Cramer offered up a framework for identifying winning stocks in this market.
“We want companies that make things and do stuff that we can understand,” the “Mad Money” host said.
CNBC’s Jim Crame... |
| 24.02.2026 | Defensive stock outperformance is flashing a warning sign for the stock market | - |
| 23.02.2026 | Novo Nordisk shares tumble after drug trial falls short | Shares in Danish drug giant Novo Nordisk have shed more than a sixth of their value after poor drug trial results sparked an investor selloff.
The firm behind weight-loss drugs Ozempic and Wegovy saw its shares tumble by 16.7 per cent to 25... |
| 23.02.2026 | HOUSE OF ROSE PROFESSIONAL ANNOUNCES 2026 BREAK THE CEILING TOUCH THE SKY® 101 BEST GLOBAL COMPANIES FOR WOMEN IN LEADERSHIP INDEX (BTC 101 GLOBAL INDEX) | NEW YORK, Feb. 23, 2026 /PRNewswire/ -- House of Rose Professional Pte. Ltd. (HORP) today announced the release of the 2026 Break the Ceiling Touch the Sky® 101 Best Global Companies for Women in Leadership Index (BTC 101 Global Index). The... |
| 23.02.2026 | Blackstone Life Sciences Partners With Johnson & Johnson To Advance Bleximenib For Acute Myeloid Leukemia | Blackstone Life Sciences announced a research and development funding agreement with Johnson & Johnson to advance the clinical development of bleximenib (JNJ-75276617), an investigational oral menin inhibitor, for acute myeloid leukemia... |
| 20.02.2026 | Curt Smith: Fighting blood cancer is easier with a group effort | - |
| 20.02.2026 | Supreme Court says Trump’s tariffs aren’t legal. These stocks should benefit most | - |
| 19.02.2026 | Thursday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 19.02.2026 | Американская фармкомпания Johnson & Johnson инвестирует $1 млрд в завод клеточной терапии в США | J&J инвестирует $1 млрд в новый завод в Пенсильвании на фоне курса США на развитие производства. Johnson & Johnson сообщила в среду, что вложит более $1 млрд в строительство нового предприятия по производству клеточной терапии в шта... |
| 19.02.2026 | 3 portfolio stocks jumped after insider buying — we’ll see if it can happen for a 4th | - |
| 13.02.2026 | Friday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 13.02.2026 | China’s Bio-Thera Gets EU’s Marketing Approval for Its Inflammatory Autoimmune Disease Drug | (Yicai) Feb. 13 -- Chinese biopharmaceutical company Bio-Thera Solutions’ Gotenfia has received regulatory approval from the European Union for the treatment of several chronic inflammatory autoimmune diseases.
Bio-Thera received the market... |
| 11.02.2026 | Eli Lilly Secures Future with Orna Therapeutics Acquisition | Eli Lilly acquired Orna Therapeutics. The deal totals up to $2.4 billion. This secures groundbreaking circular RNA technology. Orna pioneers *in vivo* cell engineering. Their platform allows the body to generate therapies internally. This b... |
| 11.02.2026 | CJ Foods Names Adam Ricciardone as Global Chief Technology Officer to Drive Global Growth and Innovation | SEOUL, South Korea, Feb. 11, 2026 /PRNewswire/ -- CJ Foods, a global leader in Korean, Asian and American cuisine, and the food business unit of CJ CheilJedang, today announced the appointment of Adam Ricciardone as its new Global Chief Tec... |
| 11.02.2026 | Thursday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 11.02.2026 | Wednesday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 10.02.2026 | «Дочка» Alphabet представила ИИ-движок для дизайна лекарств — вдвое точнее AlphaFold 3 | Isomorphic Labs, дочерняя компания Alphabet и сестринская структура Google DeepMind, представила IsoDDE (Isomorphic Labs Drug Design Engine) — единый вычислительный движок для проектирования лекарственных молекул. На самом сложном бенчмарке... |
| 10.02.2026 | Johnson & Johnson Launches the First and Only Daily Disposable Multifocal Toric Contact Lens[1] for Astigmatic Adults living with Presbyopia | The brand also expands daily disposable options for astigmatic adults with the launch of ACUVUE® OASYS MAX 1-Day for ASTIGMATISM, bringing pioneering innovation that delivers visual clarity and comfort [+],[**],[2],[3] as vision needs evolv... |
| 09.02.2026 | Фармкомпания Eli Lilly покупает американскую биотех-компанию Orna Therapeutics за $2,4 млрд | Американская фармацевтическая компания Eli Lilly (LLY.N) согласилась купить биотехнологическую компанию Orna Therapeutics за $2,4 млрд наличными, получив доступ к технологии, которая позволяет использовать собственные клетки пациентов для с... |
| 08.02.2026 | Almost 4,000 girls to attend 12th annual I Wish Festival at the RDS | Almost 4,000 female teenage students from across the island are expected to attend the 12th annual I Wish Festival at the RDS, Dublin.
The event is focused on promoting STEM subjects, science, technology, engineering, and mathematics to gir... |
| 07.02.2026 |
Cramer’s week ahead: A key jobs report. Plus, earnings from Robinhood, McDonald’s and more | Monday - Friday, 6:00 - 7:00 PM ET
CNBC’s Jim Cramer said there could be a soft jobs report next week.
He walked through upcoming earnings reports from McDonald’s, Robinhood, DuPont and several other companies.
CNBC’s Jim Cramer on Friday o... |
| 07.02.2026 | Here are 3 major moments that drove the stock market last week | - |
| 06.02.2026 | Friday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 06.02.2026 | Cramer calls this drug maker the ‘greatest growth stock.’ He also names a runner-up | - |
| 04.02.2026 | Early Alert: Heart Pump Issue from Abiomed | CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. Affected Product
The FDA is awar... |
| 03.02.2026 | Toptal Ranked #1 Most Reliable Professional Services Company in America by Newsweek | Toptal, the world’s largest fully remote workforce, has been ranked the #1 most reliable professional services company in America on the America’s Most Reliable Companies 2026 list by Newsweek and Statista. The list ranks top US companies b... |
| 03.02.2026 | Stocks making the biggest moves after hours: Chipotle, Advanced Micro Devices, Amgen and more | - |
| 02.02.2026 | Tuesday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 02.02.2026 | The AI trend can give dividend aristocrats a boost, Raymond James says | - |
| 31.01.2026 | Here is what caused the wild swings in our 34-stock portfolio last week | - |
| 30.01.2026 | Earnings, jobs loom large in the week ahead for a discerning market. Here’s what’s coming up | - |
| 30.01.2026 | This dividend fund is one of Morningstar’s best for 2026. Here are its manager’s top stock picks | - |
| 30.01.2026 | Friday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 29.01.2026 | New Board of Directors at Everdrone ahead of accelerated expansion | New Board of Directors at Everdrone ahead of accelerated expansion
Thu, Jan 29, 2026 09:53 CET Report this content
Everdrone AB announces the appointment of a new Board of Directors, following a decision at an Extraordinary General Meeting ... |
| 29.01.2026 | Thursday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 28.01.2026 | Weak dollar winners: These stocks could get a boost if Trump keeps talking the greenback lower | - |
| 28.01.2026 | Here are Wednesday’s biggest analyst calls: Apple, Amazon, Johnson & Johnson, Ferrari, Visa & more | - |
| 28.01.2026 | Wednesday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 28.01.2026 | Morgan Stanley upgrades Johnson & Johnson, sees upside on robust drug pipeline | - |
| 27.01.2026 | Trialbee to Share Vision for the Last Mile of Patient Recruitment with Expert Panel, AI Innovation, and Community Collaboration at SCOPE Summit 2026 | Featuring panelists from BMS, Biogen, and Johnson & Johnson along with the Honey Platform™ and Swedish Fika Time at Booth #706
MALMÖ, Sweden and WILMINGTON, Del., Jan. 27, 2026 /PRNewswire-PRWeb/ -- Trialbee, a global leader in technolo... |
| 27.01.2026 | Экс-сотрудник CrowdStrike применил ИИ для рассылки резюме из-за неудач с трудоустройством | Бывший программный менеджер CrowdStrike Дрей Янковски, который внезапно столкнулся с сокращением, рассказал, как он применил технологии искусственного интеллекта для поиска новой работы. Он разослал более 800 резюме и получил офер на желаем... |
| 25.01.2026 | Here are the 2 big things we’re watching in the stock market in the week ahead | - |
| 24.01.2026 | Heart Attack Survivor and Social Media Powerhouse Dr. ShantaQuilette Carter-Williams to Take Center Stage at WomenHeart's 2026 Summit | WomenHeart has announced its 2026 Summit taking place February 1-3 at the Hilton Washington DC National Mall, The Wharf. Heart attack and stroke survivor Dr. ShantaQuilette Carter-Williams, a social media powerhouse with millions of followe... |
| 22.01.2026 | Think Bioscience Secures $55M Series A for 'Undruggable' Target Therapies | Think Bioscience, a Boulder, CO-based drug discovery innovator, closed an oversubscribed $55 million Series A funding round. This substantial investment accelerates R&D and operational expansion. The firm pioneers small molecule therape... |
| 22.01.2026 | Bureau Veritas Named Accredited EcoVadis Consulting Partner | Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), has been named as an Accredited Consulting Partner by EcoVadis, the global standard for resilient, sustainable supply chains. Accredited Consulting Pa... |
| 22.01.2026 | Why the stock market may have already left this week’s tariff fears behind | - |
| 21.01.2026 | The Cargo Agency Reports Growth in Canada with New Clients, Key Hires | International marketing and advertising agency recently named 2025 Power Partner by Inc. Magazine
TORONTO, Jan. 21, 2026 /PRNewswire-PRWeb/ -- The Cargo Agency, an award-winning marketing agency, announced today that it has made a significa... |
| 21.01.2026 | Thursday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 20.01.2026 | Wednesday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 20.01.2026 | These safe stocks could ride out any extended market sell-off | - |
| 20.01.2026 | Wall Street sinks as Trump threatens 8 European countries with tariffs over Greenland | Getting your Trinity Audio player ready...
By DAMIAN J. TROISE, AP Business Writer
NEW YORK (AP) — Stocks slumped on Wall Street Tuesday after President Donald Trump threatened to hit eight European countries with new tariffs as tensions es... |
| 20.01.2026 | Another alliance of health care and AI signals why pharma stocks should be back in favor | - |
| 19.01.2026 | Here are the 3 big things we’re watching in the stock market in the week ahead | - |
| 18.01.2026 | I talked to many health CEOs out West and see big things for drug stocks | - |
| 18.01.2026 | Strategic Systems Architecture and AI Governance: The Technical Contributions of Sandeep Reddy Kaidhapuram | Share
Share
Share
Share
Email
The infrastructure governing data flow within federal agencies and global enterprises represents the vital backbone of public safety and economic stability. As digital transformation shifts toward the integrati... |
| 17.01.2026 | Proxima Secures $80M Seed Round to Redefine Drug Discovery | Proxima, an AI-native biotech firm, secured an $80 million seed funding round. DCVC led the investment. NVentures and other major investors participated. Formerly VantAI, the company now targets proximity therapeutics. It aims to revolution... |
| 17.01.2026 | Hellman & Friedman рассматривает продажу производителя медоборудования Cordis более чем за $9 млрд | По данным источников, около шести публичных компаний сектора медицинских устройств в настоящее время анализируют потенциальные заявки на приобретение Cordis.
Hellman & Friedman приобрела Cordis в 2021 году у компании Cardinal Health при... |
| 17.01.2026 | Week in review: Stocks battled a flood of news and we booked some profits | - |
| 16.01.2026 |
Cramer’s week ahead: Earnings from Netflix, Intel, Capital One, McCormick | Monday - Friday, 6:00 - 7:00 PM ET
As earnings season continues, CNBC’s Jim Cramer walked investors through next week on Wall Street.
He highlighted quarterly reports from companies including Netflix, Intel, Capital One Financial and McCorm... |
| 16.01.2026 | These stocks reporting earnings next week have a history of beating expectations | - |